Abstract |
Nonresponse, or acquired resistance to immune checkpoint inhibitors in colorectal cancer (CRC) highlight the importance of finding potential tolerance mechanisms. Low expression of major histocompatibility complex, class I (MHC-I) on the cell surface of the tumor is one of the main mechanisms of tumor escape from T-cell recognition and destruction. In this study, we demonstrated that a high level of calnexin (CANX) in the tumors is positively correlated with the overall survival in colorectal cancer patients. CANX is a chaperone protein involved in the folding and assembly of MHC-I molecules. Using miRNA target prediction databases and luciferase assays, we identified miR-148a-3p as a potential regulator of CANX. Inhibition of miR-148a-3p restores surface levels of MHC-I and significantly enhanced the effects of CD8+ T-cell-mediated immune attack in vitro and in vivo by promoting CANX expression. These results reveal that miR-148a-3p can function as a tumor promotor in CRC by targeting the CANX/MHC-I axis, which provides a rationale for immunotherapy through targeting the miR-148a-3p/CANX/MHC-I pathway in patients with CRC.
|
Authors | Jinxiu Zheng, Ting Yang, Shuhua Gao, Minrong Cheng, Ying Shao, Yanfeng Xi, Linzhi Guo, Dong Zhang, Wei Gao, Guozhen Zhang, Lijun Yang, Tao Yang |
Journal | FASEB journal : official publication of the Federation of American Societies for Experimental Biology
(FASEB J)
Vol. 35
Issue 8
Pg. e21776
(08 2021)
ISSN: 1530-6860 [Electronic] United States |
PMID | 34324740
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2021 Federation of American Societies for Experimental Biology. |
Chemical References |
- CANX protein, human
- Histocompatibility Antigens Class II
- MIRN148 microRNA, human
- MicroRNAs
- Calnexin
|
Topics |
- Animals
- CD8-Positive T-Lymphocytes
(physiology)
- Calnexin
(genetics, metabolism)
- Cell Line, Tumor
- Colorectal Neoplasms
(immunology, therapy)
- Gene Expression Regulation, Neoplastic
- Gene Silencing
- Histocompatibility Antigens Class II
(genetics, metabolism)
- Humans
- Mice
- MicroRNAs
(genetics, metabolism)
- Neoplasms, Experimental
(therapy)
|